• Info
  • Insider Trading

Chris Degnan - Insider Trading & Ownership

Location
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, PA
Summary
The estimated net worth of Chris Degnan is at least $49.1K dollars as of October 9, 2025. Chris Degnan is the Chief Financial Officer of UroGen Pharma Ltd. and owns shares of UroGen Pharma Ltd. (URGN) stock worth about $38.4K. Chris Degnan is the Chief Financial Officer of Galera Therapeutics, Inc. and owns shares of Galera Therapeutics, Inc. (GRTX) stock worth about $10.7K.
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Chris Degnan files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Chris Degnan

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
URGN UroGen Pharma Ltd. Chief Financial Officer $38.4K -$37.1K -49.1% Oct 8, 2025
GRTX Galera Therapeutics, Inc. Chief Financial Officer $10.7K Mar 13, 2023

Insider Transactions Reported by Chris Degnan:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.